CA3129649A1 - Fermentation process - Google Patents

Fermentation process Download PDF

Info

Publication number
CA3129649A1
CA3129649A1 CA3129649A CA3129649A CA3129649A1 CA 3129649 A1 CA3129649 A1 CA 3129649A1 CA 3129649 A CA3129649 A CA 3129649A CA 3129649 A CA3129649 A CA 3129649A CA 3129649 A1 CA3129649 A1 CA 3129649A1
Authority
CA
Canada
Prior art keywords
growth medium
bordetella
medium
conditioned
sterile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3129649A
Other languages
English (en)
French (fr)
Inventor
Philippe DEHOTTAY
Romain KOCKS
Quentin ZUNE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of CA3129649A1 publication Critical patent/CA3129649A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA3129649A 2019-02-22 2020-02-20 Fermentation process Pending CA3129649A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19158847.4 2019-02-22
EP19158847.4A EP3699263A1 (en) 2019-02-22 2019-02-22 Fermentation process
PCT/EP2020/054426 WO2020169703A1 (en) 2019-02-22 2020-02-20 Fermentation process

Publications (1)

Publication Number Publication Date
CA3129649A1 true CA3129649A1 (en) 2020-08-27

Family

ID=65766782

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3129649A Pending CA3129649A1 (en) 2019-02-22 2020-02-20 Fermentation process

Country Status (8)

Country Link
US (1) US12559713B2 (cg-RX-API-DMAC7.html)
EP (2) EP3699263A1 (cg-RX-API-DMAC7.html)
JP (2) JP7779736B2 (cg-RX-API-DMAC7.html)
CN (1) CN113785046B (cg-RX-API-DMAC7.html)
BR (1) BR112021015973A2 (cg-RX-API-DMAC7.html)
CA (1) CA3129649A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021010154A (cg-RX-API-DMAC7.html)
WO (1) WO2020169703A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3699263A1 (en) * 2019-02-22 2020-08-26 GlaxoSmithKline Biologicals S.A. Fermentation process
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0611208B2 (ja) * 1985-06-14 1994-02-16 三井石油化学工業株式会社 ユリ種苗の増殖法
CA2011653A1 (en) 1989-03-08 1990-09-08 Hiroshi Deno Method for culturing plant tissue, apparatus therefor and method for producing metabolite
JP3151207B2 (ja) * 1989-03-08 2001-04-03 三井化学株式会社 植物の組織培養方法及びその装置ならびに代謝産物の生産方法
JPH05304952A (ja) * 1991-10-25 1993-11-19 Hokko Chem Ind Co Ltd 細胞培養法
US5462860A (en) 1994-06-06 1995-10-31 Minnesota Mining And Manufacturing Company Conditioned culture medium for rapid growth and detection of microbes
US6190657B1 (en) * 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
AU2004227111B2 (en) * 2003-04-09 2009-05-28 Bayer Cropscience Nv. Methods and means for increasing the tolerance of plants to stress conditions
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5155942B2 (ja) 2009-06-11 2013-03-06 サンデン株式会社 スクロール型流体機械
WO2013113729A1 (en) * 2012-02-01 2013-08-08 Glaxosmithkline Biologicals S.A. Fermentation process
JP2015057951A (ja) * 2013-09-17 2015-03-30 独立行政法人農業環境技術研究所 微生物培養培地、微生物の増殖方法及び有機塩素系化合物の分解方法、並びにナノバブル液体、ナノバブル液体製造装置及びナノバブル液体の製造方法
EP3699263A1 (en) * 2019-02-22 2020-08-26 GlaxoSmithKline Biologicals S.A. Fermentation process

Also Published As

Publication number Publication date
CN113785046A (zh) 2021-12-10
EP3699263A1 (en) 2020-08-26
EP3927808A1 (en) 2021-12-29
MX2021010154A (es) 2021-12-10
BR112021015973A2 (pt) 2021-10-05
JP2022521235A (ja) 2022-04-06
US12559713B2 (en) 2026-02-24
WO2020169703A1 (en) 2020-08-27
US20220169973A1 (en) 2022-06-02
JP2026004314A (ja) 2026-01-14
CN113785046B (zh) 2024-12-03
JP7779736B2 (ja) 2025-12-03

Similar Documents

Publication Publication Date Title
EP1849860B1 (en) Process for preparing an immunogenic factor of Corynebacterium diphtheriae using a culture medium with yeast extract as aminoacid source and no protein complexes of animal origin
JP2026004314A (ja) 発酵方法
US20080248542A1 (en) Clostridium difficile culture and toxin production methods
JP6582020B2 (ja) 発酵方法
JP4917087B2 (ja) ジフテリア毒素生産のための発酵方法
CN112725223B (zh) 一种用于提高质粒发酵产量的方法
CN105518122B (zh) 用于博德特氏菌属物种的工业规模培养的化学成分确定的培养基
JP2022521235A5 (cg-RX-API-DMAC7.html)
Thalen et al. Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis
US20050089968A1 (en) Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
JP2000116395A (ja) サルモネラ分離用培地
US20200407678A1 (en) Methods of cultivating bordetella species
CN119193384B (zh) 一种鸡毒支原体高密度发酵培养工艺
TWI392737B (zh) 產製RTX毒素ApxI或ApxIII 之方法
CN120173949B (zh) 一种甲烷八叠球菌hdrE基因的靶向编辑系统及其对牛瘤胃甲烷生成影响的体外评价方法及应用
Bandyopadhyay et al. KaiA regulates intracellular oxygen dynamics in unicellular diazotrophic cyanobacteria
JP4964385B2 (ja) 細菌毒素の生成のための方法
AU600936B2 (en) New culture medium for bacteria of the bordetella genus containing etherified derivative of d-glucose and a cyclodextrin
JPS63105692A (ja) 生物学的活性物質の製造法およびその培地

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240207

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250123

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250123

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250123

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250623

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251022

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251218

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251218

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260123

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260123

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20260129